Jian Min Fang
Chief Executive Officer at REMEGEN CO., LTD.
Net worth: 84 M $ as of 2024-03-30
Profile
Jian Min Fang founded RemeGen Co., Ltd. and MabPlex International Ltd. Dr. Fang holds the position of Chairman of MabPlex International Ltd. and CEO, Executive Director & Chief Scientific Officer at RemeGen Co., Ltd. Dr. Fang is also on the board of Chinese Pharmaceutical Association, Remegen Medical Research Shanghai Co. Ltd., Remegen Biosciences, Inc. and Remegen Hong Kong Ltd. and Vice Chairman-Antibody Drug Division at China Medicinal Biotech Association. Dr. Fang received a doctorate from Dalhousie University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REMEGEN CO. LTD. CLASS H
12.79% | 2023-09-30 | 24,244,500 ( 12.79% ) | 84 M $ | 2024-03-30 |
Jian Min Fang active positions
| Companies | Position | Start |
|---|---|---|
| REMEGEN CO., LTD. | Chief Executive Officer | 2008-07-03 |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 2013-06-24 |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - |
| Remegen Biosciences, Inc. | Director/Board Member | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - |
| Chinese Pharmaceutical Association | Director/Board Member | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
Training of Jian Min Fang
| Dalhousie University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Private companies | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
- Stock Market
- Insiders
- Jian Min Fang
